|
RAB6A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.803400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.787800E-02 |
| Normal-vs-Stage2 |
1.262580E-01 |
| Normal-vs-Stage3 |
3.962700E-04 |
| Normal-vs-Stage4 |
1.82069999999923E-05 |
| Stage1-vs-Stage2 |
9.225400E-01 |
| Stage1-vs-Stage3 |
3.499900E-02 |
| Stage1-vs-Stage4 |
4.615800E-03 |
| Stage2-vs-Stage3 |
2.027000E-01 |
| Stage2-vs-Stage4 |
9.258200E-02 |
| Stage3-vs-Stage4 |
6.959400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.639910E-03 |
| Normal-vs-AfricanAmerican |
2.2932000000031E-06 |
| Normal-vs-Asian |
2.927200E-01 |
| Caucasian-vs-AfricanAmerican |
4.778500E-03 |
| Caucasian-vs-Asian |
9.603000E-01 |
| AfricanAmerican-vs-Asian |
2.561000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.360700E-04 |
| Normal-vs-Female |
3.324500E-03 |
| Male-vs-Female |
8.320400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.949900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.622600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.989440E-04 |
| Normal-vs-Age(81-100Yrs) |
1.508430E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.002000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.828600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.111800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.347800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.868600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.224600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.411800E-01 |
| Normal-vs-Grade 2 |
1.703450E-01 |
| Normal-vs-Grade 3 |
1.34780000005108E-06 |
| Normal-vs-Grade 4 |
5.99050000049672E-07 |
| Grade 1-vs-Grade 2 |
5.070000E-01 |
| Grade 1-vs-Grade 3 |
9.317400E-03 |
| Grade 1-vs-Grade 4 |
3.064100E-03 |
| Grade 2-vs-Grade 3 |
4.033200E-04 |
| Grade 2-vs-Grade 4 |
5.92729999999708E-05 |
| Grade 3-vs-Grade 4 |
1.190760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.571400E-01 |
| Normal-vs-ccB subtype |
3.966900E-04 |
| ccA subtype-vs-ccB subtype |
1.516780E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.180900E-03 |
| Normal-vs-N1 |
1.742470E-02 |
| N0-vs-N1 |
5.221000E-01 |
|
|
